Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes
International Journal of Molecular Sciences · 29.11.2025 · 26 (23) · 11599
DOI: 10.3390/ijms262311599 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.11.2025. Verfasst von Amalia Kotsifaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is increasingly recognized as a heterogeneous disease, with complexity that extends beyond the classical luminal A/B, HER2-enriched, and triple-negative framework. Advances in molecular and functional profiling have uncovered emerging subpopulations, including HER2-low, claudin-low, BRCA-deficient (“BRCAness”), and refined TNBC subsets, such as luminal AR (LAR) and basal-like immune variants, that extend beyond traditional taxonomies. These novel classifications provide additional resolutions, offering both prognostic insight and therapeutic opportunities. In this comprehensive review, we integrate evidence from genomic, epigenetic, proteomic, immune-related, and liquid biopsy biomarkers, underscoring how they define the biology of these subgroups and predict responses to targeted therapies, such as antibody–drug conjugates, PARP inhibitors, and immune checkpoint blockade. We further highlight the role of the tumor microenvironment (TME) and intratumoral heterogeneity in shaping these entities. Collectively, recognition of emerging subtypes as clinically actionable groups represents a paradigm shift from static receptor-based models to dynamic, biomarker-driven frameworks that refine prognosis, enable patient stratification, and support precision oncology in aggressive BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Surgery, Elena Venizelou Hospital, 11521 Athens, Greece.
ORCID-Profile: Martha Stathaki
Zitieren
APA
Kotsifaki, A., Kalouda, G., Karalexis, E., Stathaki, M., Metaxas, G., & Armakolas, A. (2025). Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes. International Journal of Molecular Sciences, 26(23), 11599. https://doi.org/10.3390/ijms262311599
Vancouver
Kotsifaki A, Kalouda G, Karalexis E, Stathaki M, Metaxas G, Armakolas A. Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes. International Journal of Molecular Sciences. 2025;26(23):11599. doi:10.3390/ijms262311599
BibTeX
@article{Kotsifaki2025,
author = {Kotsifaki, Amalia and Kalouda, Georgia and Karalexis, Efthymios and Stathaki, Martha and Metaxas, Georgios and Armakolas, Athanasios},
title = {Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11599},
doi = {10.3390/ijms262311599}
}
EUVIMED